QRS interval widening appears to be highly specific for the diagnosis of hyperkalemia in patients with end-stage kidney disease. ECG changes, in general, have poor sensitivities for hyperkalemia in ...
NEW YORK--(BUSINESS WIRE)--AccurKardia, an innovator in ECG-based diagnostics technology, has announced the initiation of a multicenter clinical pilot of AK+ Guard TM, an FDA Breakthrough Device ...
AccurKardia, an innovator in ECG-based diagnostics technology, today announced that AK+ Guard™ has been selected as winner of ...
—Elevated potassium levels during reperfusion can have devastating consequences for liver transplant patients. But there are few data on the predictive value of baseline levels and the timing of blood ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results